Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Bovine TB vaccine field trials given go-ahead
More than 40,000 cattle are slaughtered as a result of bTB infection annually.
Trials follow 20 years of research by government scientists.

Bovine TB (bTB) cattle vaccination trials have been given the go-ahead in England and Wales in a bid to develop a cattle vaccine by 2025.

The trials, which follow 20 years of research by government scientists, will be conducted over the next four years on behalf of Defra, the Welsh Government and the Scottish Government.

The UK's Chief Veterinary Officer, Christine Middlemiss, said that the research has been 'pivotal' in developing a potential vaccine.

“Whilst there is no single way to combat this damaging and complex disease, cattle vaccination is a potential new tool for our multi-pronged approach to tackle it and importantly prevent it, providing vital support to our farming communities,” she said.

“Bovine TB presents a global challenge and the UK has harnessed its world-leading science to develop potential solutions such as vaccination and new diagnostic tests that could also be valuable to other countries.”

The vaccine trials are one of several measures to eradicate bTB in England by 2038. Other measures include plans to phase out intensive badger culling in England, improve the cattle testing regime and vaccinate more badgers against the disease.

Environment Secretary George Eustice said: “Bovine TB is a slow-moving and insidious disease which can cause considerable trauma for farmers as they suffer the loss of highly prized animals and valued herds.

“This scientific breakthrough is a major step forwards in our battle to see the disease eradicated from this country. As wider preventative measures like cattle vaccines are introduced, we will accelerate other elements of our strategy and start to phase out badger culling in England, as no one wants to continue the cull of a protected species indefinitely.”

The British Veterinary Association said that the deployment of a viable cattle vaccine has the potential to be an 'absolute gamer changer.'

“These field trials mark the culmination of years of ground-breaking research and efforts by the veterinary scientific community to expand the range of tools available to vets and farmers to tackle bovine tuberculosis,” he said.

BTB is one of the most problematic animal health challenges in the UK. Every year, more than 40,000 cattle are slaughtered as a result of bTB infection.

Researchers say a vaccine could become a powerful tool in the battle against the disease following the necessary testing and efficacy approvals.

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.